A Novel DNA Vaccine Against SARS-CoV-2 Encoding a Chimeric Protein of Its Receptor-Binding Domain (RBD) Fused to the Amino-Terminal Region of Hepatitis B Virus preS1 With a W4P Mutation

Overview of attention for article published in Frontiers in immunology, February 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

news: 1 news outlet
twitter: 4 X users

patent: 3 patents

Citations

dimensions_citation: 19 Dimensions

Readers on

mendeley: 70 Mendeley

Summary News X Patents Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

VACCINE FOR PREVENTION OR TREATMENT OF VIRAL INFECTION

Application WO-2022250518-A1

World Intellectual Property Organisation (WIPO)

SARS-COV-2 SUBUNIT VACCINE

Application WO-2022207645-A1

World Intellectual Property Organisation (WIPO)

DNA VACCINE COMPOSITION COMPRISING HEPATITIS VIRUS B-DERIVED MUTANT MOLECULE AND PATHOGEN…

Application WO-2022146125-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.